Diabetic Kidney Disease Market
Diabetic Kidney Disease Market Size, Share & Trends Analysis Report
Diabetic Kidney Disease Market Size, Share, Statistics & Trends Analysis Report By Drug Class (Angiotensin Receptor Blockers (ARBs), Calcium Channel Blockers, Antioxidant Inflammation Modulator, Angiotensin-Converting Enzyme (ACE) Inhibitors, Others) Route of Administration Insights By Route of Administration (Oral, Parenteral) Distribution Channel Insights By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Based On Region, And Segment Forecasts, 2024 – 2030
Published
Report ID : BMRC 2979
Number of pages : 300
Published Date : Jun 2024
Category : Healthcare
Delivery Timeline : 48 hrs
Segmentation
Drug Class Insights
- Angiotensin Receptor Blockers (ARBs)
- Calcium Channel Blockers
- Antioxidant Inflammation Modulator
- Angiotensin-Converting Enzyme (ACE) Inhibitors
- Others
Route of Administration Insights
- Oral
- Parenteral
Distribution Channel Insights
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Key Players
- AstraZeneca
- Boehringer Ingelheim
- Janssen Pharmaceuticals
- Bristol Myers Squibb
- GSK
- Novo Nordisk
- Eli Lilly and Company
- Merck & Co.
- Sanofi
- AbbVie
- Sun Pharmaceutical Industries Ltd
- Teva Pharmaceutical Industries Ltd
- Lupin
- Aurobindo Pharma
- Takeda Pharmaceutical Company Limited
- Biogen
- Vertex Pharmaceuticals Incorporated
SUMMARY
Segments
Drug Class Insights
- Angiotensin Receptor Blockers (ARBs)
- Calcium Channel Blockers
- Antioxidant Inflammation Modulator
- Angiotensin-Converting Enzyme (ACE) Inhibitors
- Others
Route of Administration Insights
- Oral
- Parenteral
Distribution Channel Insights
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regions and Country
North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherlands
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of MEA
Key Players
- AstraZeneca
- Boehringer Ingelheim
- Janssen Pharmaceuticals
- Bristol Myers Squibb
- GSK
- Novo Nordisk
- Eli Lilly and Company
- Merck & Co.
- Sanofi
- AbbVie
- Sun Pharmaceutical Industries Ltd
- Teva Pharmaceutical Industries Ltd
- Lupin
- Aurobindo Pharma
- Takeda Pharmaceutical Company Limited
- Biogen
- Vertex Pharmaceuticals Incorporated
